Figure 3 shows the results of Kaplan–Meier analysis and log-rank test: in the PD–NC group (n = 142), the higher the baseline CSF GFAP level of the participants, the higher the risk of cognitive transition (MCI, p = 0.007; dementia, p = 0.021). This evidence concerns the gene GFAP and Parkinson disease.